ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $466 | -5.1% | 6,946 | -4.3% | 0.00% | 0.0% |
Q2 2023 | $491 | +33.1% | 7,257 | +6.3% | 0.00% | 0.0% |
Q1 2023 | $369 | -17.6% | 6,824 | -8.9% | 0.00% | 0.0% |
Q4 2022 | $448 | -99.8% | 7,491 | +19.3% | 0.00% | +100.0% |
Q3 2022 | $284,000 | -70.2% | 6,280 | -62.7% | 0.00% | -75.0% |
Q2 2022 | $952,000 | -25.8% | 16,831 | -6.7% | 0.00% | -20.0% |
Q1 2022 | $1,283,000 | -10.5% | 18,045 | -17.9% | 0.01% | -16.7% |
Q4 2021 | $1,434,000 | +14.3% | 21,974 | +31.4% | 0.01% | +20.0% |
Q3 2021 | $1,255,000 | +23.0% | 16,724 | +27.9% | 0.01% | +25.0% |
Q2 2021 | $1,020,000 | -11.5% | 13,078 | -7.0% | 0.00% | -33.3% |
Q1 2021 | $1,152,000 | -1.2% | 14,067 | -0.2% | 0.01% | 0.0% |
Q4 2020 | $1,166,000 | +45.2% | 14,098 | +14.0% | 0.01% | +20.0% |
Q3 2020 | $803,000 | +12.9% | 12,364 | +7.7% | 0.01% | +25.0% |
Q2 2020 | $711,000 | -3.7% | 11,481 | -0.4% | 0.00% | -33.3% |
Q1 2020 | $738,000 | -7.8% | 11,531 | -0.2% | 0.01% | +20.0% |
Q4 2019 | $800,000 | +10.0% | 11,556 | +0.6% | 0.01% | 0.0% |
Q3 2019 | $727,000 | +26.0% | 11,486 | +26.2% | 0.01% | +25.0% |
Q2 2019 | $577,000 | – | 9,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
RK Capital | 147,290 | $9,431,000 | 4.24% |
HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |